Writing for the Wall Street Journal’s opinion page, Allysia Finley explains that while randomized controlled trials can yield important insights, it is a medical mistake and a disservice to patients to dismiss other types of evidence. Very relevant in the context of COVID-19 treatments, especially hydroxychloroquine. “Some experts have dismissed the antimalarial hydroxychloroquine, or […]